In 2010, young researchers from developing countries were invited by the Institute of Tropical Medicine (ITM) in Belgium to join in the scientific debate and actively participate in the First […]
Guest writers
Krishna Chinthapalli: How to read the unconscious mind
Years ago, I stumbled across Roald Dahl’s macabre short stories whilst looking for tales of chocolate factories and witches’ conferences. In one of the most famous stories, William and Mary, […]
Kailash Chand on the NHS commissioning board
In the Department of Health’s guidance Developing the NHS Commissioning Board, David Nicholson stated: “CCGs (Clinical Commissioning Groups) will be the engine of the new system and things will only […]
Katy Cooper: NCDs, MDGs, SDGs – a crowded space explained
Since the United Nations (UN) high-level Meeting on non-communicable diseases (NCDs) in September 2011 things have got busy—and potentially confusing. Running in parallel to the establishment of a new “global […]
Rob Hampton: Long term absence needs to be case managed
At the end of November the government will give its response to last year’s sickness absence review led by business leader David Frost and healthcare expert Dame Carol Black. A […]
Fred Kavalier: Not very harmonious
Newspapers these days have a steady stream of stories about the alleged failings and dirty dealings of private companies who are providing services to the NHS. Saturday’s Guardian (10 November […]
Ian Liddell-Grainger: What more can be done to improve patient access to medical technologies?
Despite an increasing number of medical technologies that have the power to save and enhance lives, a high proportion of healthcare professionals still believe that the NHS has been too […]
Desmond O’Neill: The location of Ireland’s new national children’s hospital
One of the hottest topics in Irish medical politics finally came to a head this week with the announcement of the location of the new national childrens’ hospital, amalgamating the […]
Jennifer McAughey, Sarah Walpole, and Merav Kliner: When generics are more expensive than trade name drugs
Over the last few decades we have become used to the questionable practices of drug companies when profits are at stake. Recent reports on the actions […]
Kasia Malinowska-Sempruch: An opportunity for EU member states to save money and lives
In the coming months, officials will sign the next EU drugs strategy providing a drug policy framework for EU institutions and member states. Past drug strategies have called for a […]